Xue Gang Wang
Geen lopende functies
Profiel
Xue Gang Wang founded iGeneTech Bioscience Co., Ltd.
in 2014.
Mr. Wang also formerly worked at ACROBiosystems Co., Ltd., as Director.
Mr. Wang received his graduate degree from the University of Aarhus.
Eerdere bekende functies van Xue Gang Wang
| Bedrijven | Functie | Einde |
|---|---|---|
| ACROBIOSYSTEMS CO.,LTD. | Directeur/Bestuurslid | - |
iGeneTech Bioscience Co., Ltd.
 iGeneTech Bioscience Co., Ltd. BiotechnologyHealth Technology iGeneTech Bioscience Co., Ltd. is a Chinese biotechnology company founded in 2014 by Rui Chao Wang, Xue Gang Wang, Wu Bin Qu, Xing Yi Hang, with Wanshi Cai as the CEO. The company is based in Beijing, China. The company specializes in developing and supplying solutions for target gene "reading" and "writing" technology, with NGS probe hybridization, multiplex PCR, and high-throughput DNA synthesis as its core technology platforms. iGeneTech offers customized development of gene capture products, NGS IVD product CDMO services, targeted sequencing laboratory solutions, NGS sequencing rapid detection services, and large-scale DNA synthesis services to global partners. | Oprichter | - |
Opleiding van Xue Gang Wang
| University of Aarhus | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ACROBIOSYSTEMS CO.,LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
iGeneTech Bioscience Co., Ltd.
iGeneTech Bioscience Co., Ltd. BiotechnologyHealth Technology iGeneTech Bioscience Co., Ltd. is a Chinese biotechnology company founded in 2014 by Rui Chao Wang, Xue Gang Wang, Wu Bin Qu, Xing Yi Hang, with Wanshi Cai as the CEO. The company is based in Beijing, China. The company specializes in developing and supplying solutions for target gene "reading" and "writing" technology, with NGS probe hybridization, multiplex PCR, and high-throughput DNA synthesis as its core technology platforms. iGeneTech offers customized development of gene capture products, NGS IVD product CDMO services, targeted sequencing laboratory solutions, NGS sequencing rapid detection services, and large-scale DNA synthesis services to global partners. | Health Technology |
